about
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variantsUlcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association studyEarly post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease.Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients.Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease.Crohn's Disease Localization Displays Different Predisposing Genetic VariantsRandomised controlled trial of mesalazine in IBS.Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia.Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study.Transperineal ultrasonography: First level exam in IBD patients with perianal disease.Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis.Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.Estimates of HCV-1 patients attaining RVR following dual therapy with peg-interferon and ribavirin.Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind Sham-controlled study.Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study.Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels.Erratum: Corrigendum: Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association studyPatient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD studyDissecting the mucosal expression of human leucine-rich repeat family genes in inflammatory bowel disease patientsThe association of MYO9B gene in Italian patients with inflammatory bowel diseasesPolymorphisms of Tumor Necrosis Factor-α but Not MDR1 Influence Response to Medical Therapy in Pediatric-Onset Inflammatory Bowel DiseaseSequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacyLetter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanomaImpact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: Association with IL33 gene variantIL23R, ATG16L1, IRGM, OCTN1, and OCTN2 mRNA expression in inflamed and noninflamed mucosa of IBD patientsThe −A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's DiseaseContinuous Infusion Versus Bolus Administration of Steroids in Severe Attacks of Ulcerative Colitis: A Randomized, Double-Blind Trial
P50
Q24617796-8956B195-138F-4FBA-950E-95411CD1BE4DQ24643514-8960A811-4D31-4D11-B765-7B637C01CAC1Q30778152-C94C9FF5-DC98-459B-AB15-4F134445BE91Q30938527-669B7977-D42C-4FCB-93A6-656037FA24EAQ33983369-C916DAF2-F4CD-443B-B020-9D0AB7EC2E61Q34089176-16F0FBC8-AC15-4A41-9D07-D2D2097E2FD5Q34698326-6A47DB36-F9B0-4DE7-A285-821818D44434Q36239381-687B0AA0-10EB-4B1E-9F08-8C43625EE0A9Q36475502-2E526BD9-D888-42CA-A387-820E62D1B8F7Q37166742-5B292F4D-4110-4A88-B46F-FF9727C2C767Q37335103-365C4835-7588-463F-84CF-955D3D234EF3Q37495746-26569517-77BA-4051-974D-85843F2DFB0DQ38813556-101CB20E-63F3-43DF-AD65-AC175522AE1EQ39315460-D7E0AABC-0687-4412-9A39-20104EFEDD79Q40672348-BAAFD107-62DA-4380-8B05-FB5B5E8E6739Q41076943-C0338749-F3D2-4CFB-9796-39FB4496BDCDQ42155343-FC72C3F3-BCAA-41F0-84AF-F05A42CFE09DQ42788674-10510D11-4441-4ED3-9B64-FFA53AF5CBC9Q42986651-A4539655-A2C8-4BE2-83A6-2B1C07DCA423Q43407161-6E97241A-0742-4157-A2E9-F987E7E7BCDAQ44934345-E81F294F-977D-40F0-B29D-F0CC8E636181Q45124275-C98A0F8F-D338-45A4-A0FC-A43175631F10Q45899366-2CE16A8B-37AC-4194-A60A-9845DEADD911Q46818061-AE0A1315-CE73-4929-A948-E213B6F1AC2EQ47280430-39D79ED4-57C1-4AAF-9727-6BFD9638FE4DQ47438914-AE205B5A-50D3-413A-B0E8-E579097C01EDQ51696292-54D9ED29-A6BC-41B9-A29C-6F8312CCEE33Q52931257-9C0F1C1D-F9EF-4FD2-BB23-16012B33AE89Q53648903-915C799E-648B-420C-8087-E8765C517085Q57418172-5C5070FC-A878-41FD-B890-F3B6254C4497Q57662336-F9521932-FF1A-418B-A18D-62FE75D5BCF5Q57748241-E3EC7DA6-506B-49D9-8530-D8134FB29D42Q57804302-DA451375-4B2B-497E-8DC8-25B274E5D687Q57804334-DFA88E1C-74CF-44DB-961D-CB8900087256Q57804342-D21149A9-42ED-4A2A-BF83-8832E2C8EFCCQ58945111-24962051-E6CF-44B0-912D-9A9628CC52FCQ59348478-603BDDFC-910F-468F-80C5-19695B44DC36Q60023145-C2612D59-1579-4A8E-B8A4-ED0E0A5856C2Q60023210-38E2E0D6-B80C-46F7-B9BE-E25C8FEB022CQ60023304-E8C4012F-0639-4DEB-89B3-12C8598D573F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabrizio Bossa
@ast
Fabrizio Bossa
@en
Fabrizio Bossa
@es
Fabrizio Bossa
@nl
Fabrizio Bossa
@sl
type
label
Fabrizio Bossa
@ast
Fabrizio Bossa
@en
Fabrizio Bossa
@es
Fabrizio Bossa
@nl
Fabrizio Bossa
@sl
prefLabel
Fabrizio Bossa
@ast
Fabrizio Bossa
@en
Fabrizio Bossa
@es
Fabrizio Bossa
@nl
Fabrizio Bossa
@sl
P1053
B-3078-2017
P106
P1153
9840990700
P21
P31
P3829
P496
0000-0002-4518-9949